| 產(chǎn)品名稱 | OTX 015 |
| 產(chǎn)品貨號 | Axon 2530 CAS [202590-98-5] MF C25H22ClN5O2SMW 491.99 Purity: 99% Optical purity: Optically pure Soluble in DMSO and ethanol Description Potent inhibitor of BRD2, BRD3, and BRD4 (Ki values ranging from 3.2 to 24.7 nM, considering BDs 1 and 2), with clear anti-proliferative activity on a large number of diffuse large B-cell lymphoma (DLBCL) cell lines. OTX 015 inhibits the growth of hematologic malignances through directly regulating MYC expression and activity. KEYWORDS: OTX 015 | supplier | BET-BRD inhibitor | OTX015 | CAS [202590-98-5] | Histone | BET (BRD) | Inhibitor | BRD2 | BRD3 | BRD4 | tumor | apoptosis | G1 | cell cycle | diffuse large B-cell lymphoma | DLBCL | MYC |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
OTX 015Axon 2530 CAS [202590-98-5] MF C25H22ClN5O2S
DescriptionPotent inhibitor of BRD2, BRD3, and BRD4 (Ki values ranging from 3.2 to 24.7 nM, considering BDs 1 and 2), with clear anti-proliferative activity on a large number of diffuse large B-cell lymphoma (DLBCL) cell lines. OTX 015 inhibits the growth of hematologic malignances through directly regulating MYC expression and activity. KEYWORDS: OTX 015 | supplier | BET-BRD inhibitor | OTX015 | CAS [202590-98-5] | Histone | BET (BRD) | Inhibitor | BRD2 | BRD3 | BRD4 | tumor | apoptosis | G1 | cell cycle | diffuse large B-cell lymphoma | DLBCL | MYC
Potent inhibitor of BRD2, BRD3, and BRD4 with clear anti-proliferative activity
Chemical name(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide Parent CAS No.[202590-98-5] |
| 產(chǎn)品資料 |
